다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Cancer discovery, v.2 no.3, 2012년, pp.236 - 247
Benassi, Barbara , Flavin, Richard , Marchionni, Luigi , Zanata, Silvio , Pan, Yunfeng , Chowdhury, Dipanjan , Marani, Marina , Strano, Sabrina , Muti, Paola , Blandino, Giovanni , Loda, Massimo
AI-Helper
AbstractUbiquitin-specific protease 2a (USP2a) is overexpressed in almost half of human prostate cancers and c-Myc is amplified in one third of these tumor types. Transgenic MYC expression drives invasive adenocarcinomas in the murine prostate. We show that overexpression of USP2a downregulates a se...
Oncogene Nesbit 18 3004 1999 10.1038/sj.onc.1202746 MYC oncogenes and human neoplastic disease
J Natl Cancer Inst Sato 91 1574 1999 10.1093/jnci/91.18.1574 Clinical significance of alterations of chromosome 8 in high-grade, advanced, nonmetastatic prostate carcinoma
Cancer Cell Ellwood-Yen 4 223 2003 10.1016/S1535-6108(03)00197-1 Myc-driven murine prostate cancer shares molecular features with human prostate tumors
Nat Genet Chang 40 43 2008 10.1038/ng.2007.30 Widespread microRNA repression by Myc contributes to tumorigenesis
Neoplasia Dai 8 630 2006 10.1593/neo.06334 Balance of Yin and Yang: ubiquitylation-mediated regulation of p53 and c-Myc
Nature He 435 828 2005 10.1038/nature03552 A microRNA polycistron as a potential human oncogene
Nat Cell Biol Popov 9 765 2007 10.1038/ncb1601 The ubiquitin-specific protease USP28 is required for MYC stability
Oncogene Wei 27 5204 2008 10.1038/onc.2008.154 The MYCN oncogene is a direct target of miR-34a
Cancer Res Ambs 68 6162 2008 10.1158/0008-5472.CAN-08-0144 Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer
Proc Natl Acad Sci U S A Volinia 103 2257 2006 10.1073/pnas.0510565103 A microRNA expression signature of human solid tumors defines cancer gene targets
Nat Genet Kumar 39 673 2007 10.1038/ng2003 Impaired microRNA processing enhances cellular transformation and tumorigenesis
BMC Mol Biol Koscianska 8 79 2007 10.1186/1471-2199-8-79 Prediction and preliminary validation of oncogene regulation by miRNAs
J Pathol Leucci 216 440 2008 10.1002/path.2410 MYC translocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation
Proc Natl Acad Sci U S A Sachdeva 106 3207 2009 10.1073/pnas.0808042106 p53 represses c-Myc through induction of the tumor suppressor miR-145
Cancer Res Sampson 67 9762 2007 10.1158/0008-5472.CAN-07-2462 MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells
Nature O'Donnell 435 839 2005 10.1038/nature03677 c-Myc-regulated microRNAs modulate E2F1 expression
Cell Nijman 123 773 2005 10.1016/j.cell.2005.11.007 A genomic and functional inventory of deubiquitinating enzymes
Cell Cycle Cummins 3 689 2004 10.4161/cc.3.6.924 HAUSP is required for p53 destabilization
Nature Li 416 648 2002 10.1038/nature737 Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization
Mol Cell Meulmeester 18 565 2005 10.1016/j.molcel.2005.04.024 Loss of HAUSP-mediated deubiquitination contributes to DNA damage-induced destabilization of Hdmx and Hdm2
Mol Cell Shan 36 469 2009 10.1016/j.molcel.2009.10.018 Suppression of cancer cell growth by promoting cyclin D1 degradation
Embo J Stevenson 26 976 2007 10.1038/sj.emboj.7601567 The deubiquitinating enzyme USP2a regulates the p53 pathway by targeting Mdm2
Cancer Cell Graner 5 253 2004 10.1016/S1535-6108(04)00055-8 The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer
Cancer Res Priolo 66 8625 2006 10.1158/0008-5472.CAN-06-1374 The isopeptidase USP2a protects human prostate cancer from apoptosis
Proc Natl Acad Sci U S A Shi 104 19983 2007 10.1073/pnas.0706641104 An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells
Cancer Gene Ther Tong 16 206 2009 10.1038/cgt.2008.77 MicroRNA profile analysis of human prostate cancers
Cancer Res Berger 64 8867 2004 10.1158/0008-5472.CAN-04-2938 Androgen-induced differentiation and tumorigenicity of human prostate epithelial cells
Mol Cell Biol Shah 27 4238 2007 10.1128/MCB.00317-07 Peroxisome proliferator-activated receptor alpha regulates a microRNA-mediated signaling cascade responsible for hepatocellular proliferation
Cancer Cell Taylor 18 11 2010 10.1016/j.ccr.2010.05.026 Integrative genomic profiling of human prostate cancer
Cancer Res Corney 67 8433 2007 10.1158/0008-5472.CAN-07-1585 MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth
Cancer Cell Hermeking 12 414 2007 10.1016/j.ccr.2007.10.028 p53 enters the microRNA world
Nature Bild 439 353 2006 10.1038/nature04296 Oncogenic pathway signatures in human cancers as a guide to targeted therapies
Nucleic Acids Res Megraw 35 D149 2007 10.1093/nar/gkl904 miRGen: a database for the study of animal microRNA genomic organization and function
J Biol Chem Wu 277 36329 2002 10.1074/jbc.M204962200 Transcriptional regulation during p21WAF1/CIP1-induced apoptosis in human ovarian cancer cells
Nat Genet Tomlins 39 41 2007 10.1038/ng1935 Integrative molecular concept modeling of prostate cancer progression
Nature Amati 359 423 1992 10.1038/359423a0 Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max
Mod Pathol Gurel 21 1156 2008 10.1038/modpathol.2008.111 Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis
Nat Rev Mol Cell Biol Adhikary 6 635 2005 10.1038/nrm1703 Transcriptional regulation and transformation by Myc proteins
Cell Ayer 72 211 1993 10.1016/0092-8674(93)90661-9 Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity
Anticancer Drugs Bressin 17 181 2006 10.1097/00001813-200602000-00009 Decrease in c-Myc activity enhances cancer cell sensitivity to vinblastine
Curr Opin Oncol el-Deiry 9 79 1997 10.1097/00001622-199701000-00013 Role of oncogenes in resistance and killing by cancer therapeutic agents
Genes Chromosomes Cancer Hattinger 48 289 2009 10.1002/gcc.20640 Mechanisms of gene amplification and evidence of coamplification in drug-resistant human osteosarcoma cell lines
Ann Rev Med Garzon 60 167 2009 10.1146/annurev.med.59.053006.104707 MicroRNAs in Cancer
Cancer Invest Adams 22 304 2004 10.1081/CNV-120030218 Development of the proteasome inhibitor Velcade (Bortezomib)
Chem Biol Liu 10 837 2003 10.1016/j.chembiol.2003.08.010 Discovery of inhibitors that elucidate the role of UCH-L1 activity in the H1299 lung cancer cell line
Methods Livak 25 402 2001 10.1006/meth.2001.1262 Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C[T]) method
Cancer Cell Singh 1 203 2002 10.1016/S1535-6108(02)00030-2 Gene expression correlates of clinical prostate cancer behavior
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.